Skip to main content
GENINUS Inc. logo

GENINUS Inc. — Investor Relations & Filings

Ticker · 389030 ISIN · KR7389030008 KO Professional, scientific and technical activities
Open in API
Filings indexed 149 across all filing types
Latest filing 2024-03-20 Audit Report / Informat…
Country KR South Korea
Listing KO 389030

About GENINUS Inc.

https://www.kr-geninus.com/

GENINUS Inc. is a biotechnology company specializing in genomic and multi-omics analysis for precision medicine. The company provides comprehensive solutions for drug development, diagnostics, and clinical research, with a focus on single-cell analysis, cancer genome companion diagnostics, and AI-driven biomarker discovery. Its proprietary platforms include IntelliMed™ for clinical genomics, MEDINSIGHT™ for AI-powered digital pathology, and SPACEINSIGHT™, a cloud-based platform for spatial multi-omics data analysis. By integrating advanced analytics with artificial intelligence, GENINUS delivers genetic insights to support personalized treatment strategies, disease prevention, and the development of novel therapeutics.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from the company Geninus. It provides a summary of the audit results, including financial statements (assets, liabilities, equity, profit/loss) for the current and previous fiscal years, as well as auditor information. While it contains financial data, it is a standard regulatory disclosure of the audit outcome rather than the full Annual Report (10-K) or a standalone audit report document. In the context of Korean regulatory filings (DART), this is classified as an audit report submission announcement. FY 2023
2024-03-20 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Geninus Inc. It contains the agenda for the upcoming Annual General Meeting (AGM), including items such as the approval of financial statements, election of directors, and remuneration limits. It also includes management's business report and financial statements as reference materials for shareholders. This document is a standard proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their votes.
2024-03-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often referred to as a Proxy Solicitation Statement). It contains information regarding the upcoming Annual General Meeting (AGM), including the agenda, voting procedures, and proxy solicitation details. While it contains financial data, it is primarily a proxy solicitation document rather than an Annual Report (10-K) or an Interim Report (IR). Therefore, it is classified as a Proxy Solicitation & Information Statement.
2024-03-13 Korean
타인에대한채무보증결정
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from a Korean company (Geninus) regarding a 'Decision on Debt Guarantee for Others' (타인에 대한 채무보증결정). This is a standard corporate disclosure required by the Capital Markets Act in Korea for material events. Since it does not fit into specific categories like earnings releases, dividends, or board changes, and is a formal regulatory disclosure of a financial guarantee, it falls under the 'Regulatory Filings' category.
2024-03-04 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by the company Geninus. It details the date, location, and agenda items (such as approval of financial statements, election of directors, and remuneration limits). This type of document is a standard proxy solicitation material provided to shareholders to inform them of upcoming meeting details and voting items, which falls under the Proxy Solicitation & Information Statement category.
2024-02-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (Geninus) regarding a significant change in revenue or profit structure (30% or more). This is a standard regulatory disclosure requirement in the Korean market (DART system) for listed companies to report material financial changes before the final audit is completed. Since it is a specific regulatory disclosure of financial performance highlights rather than a full annual report or a simple announcement of a report's publication, it falls under the 'Regulatory Filings' category. FY 2023
2024-02-05 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.